Pricing Log in Create free account

Insmed, Inc. (INSM) vs Roivant Sciences Ltd. (ROIV)

Insmed, Inc. and Roivant Sciences Ltd. are both Biotechnology companies. Roivant Sciences Ltd. is the larger, with a market value of $26.5B against $23.9B — 1.1× the size. Insmed, Inc. grew revenue faster over the last twelve months: 240.0% against −67.6%. Insmed, Inc. has the higher net margin (−39.9% vs −3,535.0%) and the lower return on invested capital (−247.6% vs −34.5%). Across the 18 metrics below, Insmed, Inc. leads on 11 and Roivant Sciences Ltd. on 7.

Valuation

Metric INSM ROIV Biotechnology median
P/E n/m n/m 10.26
P/S 15.60 3,528.29 9.18
P/B 32.64 5.40 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 15.36 3,061.16 8.98
Earnings yield (2.60%) (1.03%) (34.89%)
Free cash flow yield (2.65%) (3.09%) (24.52%)

Profitability

Metric INSM ROIV Biotechnology median
Gross margin 84.40% 81.21% 65.16%
Operating margin (37.11%) (7,914.75%) 0.00%
Net margin (39.85%) (3,534.96%) 0.00%
Free cash flow margin (41.30%) (10,901.00%) 0.00%
Return on equity (72.45%) (5.47%) (50.12%)
Return on assets (26.41%) (5.15%) (45.60%)
Return on invested capital (247.55%) (34.51%) 0.00%

Growth

Metric INSM ROIV Biotechnology median
Revenue growth (TTM) 239.97% (67.58%) 6.26%
EPS growth (last fiscal year) (15.26%) (125.00%) 29.88%
Revenue growth, 5-year CAGR 29.83% (19.07%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INSM ROIV Biotechnology median
Debt to equity 0.78 0.00 0.00
Current ratio 2.86 16.72 4.89
Net debt to EBITDA 0.71 8.39 1.01

Dividend

Metric INSM ROIV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INSM ROIV Biotechnology median
Market cap 23.86b 26.45b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack